Literature DB >> 3780776

Unusual metastatic chondrosarcoma detected with bone scintigraphy.

R Abello, F Lomeña, A Garcia, R Herranz, J Fernandez Sola, V Plaza, M Sole, J Setoain.   

Abstract

A case is presented of a scapular chondrosarcoma which showed intense uptake of Tc99m MDP in the primary tumour and in pleural and osseous metastases. Additionally, there was intense visualization of the malignant pleural effusion. The bone scintigraphy correctly diagnosed the extent of the involvement. This finding is unusual because chondrosarcomas in such a disseminated state are relatively rare.

Entities:  

Mesh:

Year:  1986        PMID: 3780776     DOI: 10.1007/bf00251996

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  9 in total

1.  Accumulation of 99mTc-diphosphonate in malignant pleural effusions: detection and verification.

Authors:  M E Siegel; W J Walker; J L Campbell
Journal:  J Nucl Med       Date:  1975-10       Impact factor: 10.057

2.  Comparison of computed tomography and other imaging modalities in the evaluation of musculoskeletal tumors.

Authors:  E Levine; K R Lee; J R Neff; N F Maklad; R G Robinson; D F Preston
Journal:  Radiology       Date:  1979-05       Impact factor: 11.105

3.  Chondrosarcoma of the pelvis and upper end of the femur. An analysis of factors influencing survival time in one hundred and thirteen cases.

Authors:  R C Marcove; V Miké; R V Hutter; A G Huvos; H Shoji; T R Miller; R Kosloff
Journal:  J Bone Joint Surg Am       Date:  1972-04       Impact factor: 5.284

4.  Scintigraphy of benign exostoses and exostotic chondrosarcomas.

Authors:  T M Hudson; F S Chew; B J Manaster
Journal:  AJR Am J Roentgenol       Date:  1983-03       Impact factor: 3.959

5.  Scintigraphic evaluation of primary bone tumors. Comparison of technetium-99m phosphonate and gallium citrate imaging.

Authors:  M A Simon; P T Kirchner
Journal:  J Bone Joint Surg Am       Date:  1980-07       Impact factor: 5.284

6.  Bone scintigraphy in hereditary multiple exostoses.

Authors:  D A Epstein; E J Levin
Journal:  AJR Am J Roentgenol       Date:  1978-02       Impact factor: 3.959

7.  Numerical assessment of bone scintigraphy in primary bone tumors and tumor-like conditions.

Authors:  O Sneppen; J Heerfordt; I Dissing; M Jensen; J Møller; M Nørbjerg
Journal:  J Bone Joint Surg Am       Date:  1978-10       Impact factor: 5.284

8.  Radionuclide bone scanning of medullary chondrosarcoma.

Authors:  T M Hudson; F S Chew; B J Manaster
Journal:  AJR Am J Roentgenol       Date:  1982-12       Impact factor: 3.959

9.  Abnormal radionuclide deposition patterns adjacent to focal skeletal lesions.

Authors:  J H Thrall; G E Geslien; R J Corcoron; M C Johnson
Journal:  Radiology       Date:  1975-06       Impact factor: 11.105

  9 in total
  5 in total

1.  Metastasis of chondrosarcoma.

Authors:  T Ozaki; A Hillmann; N Lindner; S Blasius; W Winkelmann
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Is bone scintigraphy necessary in the initial surgical staging of chondrosarcoma of bone?

Authors:  Hassan Douis; Steven L James; Robert J Grimer; Mark A Davies
Journal:  Skeletal Radiol       Date:  2011-09-03       Impact factor: 2.199

Review 3.  Extensive skeletal metastases from chondrosarcoma without pulmonary involvement.

Authors:  D G Disler; A E Rosenberg; D Springfield; J X O'Connell; D I Rosenthal; S V Kattapuram
Journal:  Skeletal Radiol       Date:  1993-11       Impact factor: 2.199

4.  Is Skeletal Imaging Essential in the Staging Workup for Conventional Chondrosarcoma?

Authors:  Ashish Gulia; Vineet Kurisunkal; Ajay Puri; Nilendu Purandare; Srinath Gupta; Venkatesh Rangarajan Drm
Journal:  Clin Orthop Relat Res       Date:  2020-11       Impact factor: 4.755

5.  Importance of Skeletal Staging in Chondrosarcoma of Bone: Results of Survey on Current Practices Among Musculoskeletal Oncologists.

Authors:  Ashish Gulia; Srinath Gupta; Vineet Kurisunkal; Ajay Puri
Journal:  Indian J Orthop       Date:  2020-05-06       Impact factor: 1.251

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.